Cargando…
Antiplatelet therapy with or without PPIs for the secondary prevention of cardiovascular diseases in patients at high risk of upper gastrointestinal bleeding: A systematic review and meta-analysis
Recurrent upper gastrointestinal (UGI) and cardiovascular (CV) events of the three antiplatelet therapies in patients with cardiovascular diseases (CVD) were compared. Studies published in the PubMed, Embase, and Cochrane Central Register of Controlled Trials electronic databases that compared diffe...
Autores principales: | Wu, Wenfa, Liu, Jia, Yu, Huiwen, Jiang, Zuofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187804/ https://www.ncbi.nlm.nih.gov/pubmed/32346423 http://dx.doi.org/10.3892/etm.2020.8657 |
Ejemplares similares
-
PPIs and Beyond: A Framework for Managing Anticoagulation-Related Gastrointestinal Bleeding in the Era of COVID-19
por: Patel, Parita, et al.
Publicado: (2020) -
Acute Middle Gastrointestinal Bleeding Risk Associated with NSAIDs, Antithrombotic Drugs, and PPIs: A Multicenter Case-Control Study
por: Nagata, Naoyoshi, et al.
Publicado: (2016) -
Upper Gastrointestinal Bleed Secondary to Duodenal Ischemia
por: Gupta, Anupam K, et al.
Publicado: (2020) -
Bleeding and pneumonia in intensive care unit patients given PPIs and H2RAs for prevention of stress ulcer: a meta analysis
por: Zhou, J, et al.
Publicado: (2010) -
Recurrent Non-Variceal Upper Gastrointestinal Bleeding among Patients Receiving Dual Antiplatelet Therapy
por: Yoo, Ah Young, et al.
Publicado: (2023)